Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSS2300038	Nirsevimab注射液	nirsevimab	Injection	Biological Products(3.1)	Import Drug Application	2023-05-12		AstraZeneca AB;Patheon Manufacturing Services LLC			view
JXSS2300037	Nirsevimab注射液	nirsevimab	Injection	Biological Products(3.1)	Import Drug Application	2023-05-12		AstraZeneca AB;Patheon Manufacturing Services LLC			view
JTS2200066	Nirsevimab注射液	nirsevimab	Injection	Biological Products	Disposable Import Drug Application	2022-08-25		AstraZeneca AB;Patheon Manufacturing Services LLC;AstraZeneca Global R&D (China) Co Ltd			view
JTS2200067	Nirsevimab注射液	nirsevimab	Injection	Biological Products	Disposable Import Drug Application	2022-08-25		AstraZeneca AB;Patheon Manufacturing Services LLC;AstraZeneca Global R&D (China) Co Ltd			view
JTS2200037	Nirsevimab注射液	nirsevimab	Injection	Biological Products	Disposable Import Drug Application	2022-06-13		AstraZeneca AB;Patheon Manufacturing Services LLC;AstraZeneca Global R&D (China) Co Ltd			view
JTS2200038	Nirsevimab注射液	nirsevimab	Injection	Biological Products	Disposable Import Drug Application	2022-06-13		AstraZeneca AB;Patheon Manufacturing Services LLC;AstraZeneca Global R&D (China) Co Ltd			view
JXSL2000141	Nirsevimab注射液	nirsevimab	Injection	Biological Products(1)	Import Drug Application	2020-08-05	AstraZeneca AB	AstraZeneca AB	In Review	2020-08-04	view